eWeight Medical

eWeight Medical operates as a telehealth-focused weight loss and metabolic health clinic serving patients across ten states: Arizona, Colorado, Delaware, Iowa, Maine, Maryland, Massachusetts, Montana, New Mexico, and North Dakota. Based in Kensington, Maryland, the clinic structures its programs around physician-supervised protocols that integrate GLP-1 receptor agonist medications with nutritional guidance and ongoing monitoring. Each patient receives an initial consultation to establish baseline metabolic markers, weight loss targets, and any contraindications before beginning treatment.

The clinic's primary pharmaceutical interventions include Semaglutide and Tirzepatide, both FDA-approved GLP-1 medications that regulate appetite and glucose metabolism. Semaglutide is administered as a once-weekly subcutaneous injection, while Tirzepatide combines GLP-1 and GIP receptor agonism for dual incretin activity. eWeight Medical also offers NAD+ supplementation protocols, which patients use alongside weight loss medications to support cellular energy production and metabolic function during caloric restriction. Dosing schedules are individualized based on patient response, tolerance, and weight loss velocity, with titration adjustments made during follow-up consultations.

The clinic's telehealth model eliminates geographic barriers for patients in its licensed states, allowing consultations, prescription management, and progress tracking through secure video appointments. Patients receive medications via mail-order pharmacy partners, with injection supplies and detailed administration instructions included. The program structure includes regular check-ins to assess side effect profiles, adjust dosing, and address questions about injection technique or dietary modifications. This remote care framework has generated a 4.9-star rating across 68 Google reviews, with patients frequently noting the accessibility of providers and clarity of program expectations.

eWeight Medical's approach to hormone optimization focuses on how metabolic hormones—particularly insulin, leptin, and incretins—affect weight regulation and body composition. Providers evaluate thyroid function, cortisol patterns, and sex hormone levels when these factors appear to impede weight loss progress. The clinic does not position itself as a full-spectrum hormone replacement therapy provider but addresses hormonal contributors to metabolic dysfunction within the context of weight management. Patients with complex endocrine conditions are often co-managed with endocrinologists or referred for specialized care.

New patients begin with a comprehensive intake that covers medical history, current medications, previous weight loss attempts, and lifestyle factors including sleep quality, stress levels, and physical activity capacity. The clinic provides educational resources on GLP-1 mechanism of action, expected timelines for appetite suppression and weight reduction, and strategies for maintaining muscle mass during weight loss. Pricing structures are transparent and discussed during initial consultations, with patients understanding monthly medication costs, consultation fees, and any laboratory work required for ongoing monitoring. The telehealth format allows eWeight Medical to serve rural communities in states like Montana and North Dakota where access to specialized weight loss care may otherwise require significant travel.